常见恶性实体肿瘤中医药全程管理浙江省专家共识(2025版)  

Consensus of Zhejiang experts on whole-process management of common malignant solid tumors with traditional Chinese medicine(2025 edition)

在线阅读下载全文

作  者:浙江省医学会肿瘤学分会 郭勇全国名老中医药专家学术经验传承工作室 马胜林[4] 郭勇[2,3] 徐至理 李妍 谷建钟[2] Zhejiang Medical Association Oncology Branch;Guo Yong National Veteran TCM Expert Academic Experience Inheritance and Cultivation Studio;Ma Shenglin;Guo Yong

机构地区:[1]不详 [2]浙江中医药大学附属第一医院 [3]浙江大学医学院附属第二医院 [4]杭州市肿瘤医院

出  处:《实用肿瘤杂志》2025年第2期97-104,共8页Journal of Practical Oncology

基  金:“十三五”浙江省中医药(中西医结合)重点学科建设计划:中西医结合肿瘤证候学(2017-XK-A09);国家自然科学基金(81973805);浙江省2022全国名老中医药专家传承工作室建设项目;2024年浙江省中医药科技计划(2024ZL382)。

摘  要:随着每年肿瘤登记数据的增长,抗肿瘤药物历经了从放化疗到靶免治疗时代的发展。多种因素可影响到抗肿瘤全程布局下的患者生存获益,包括规范化的抗肿瘤治疗、每一线抗肿瘤现代治疗的完成度、基础疾病、体力状态、现代治疗毒性反应、不可耐受的肿瘤相关症状和社会经济学因素等。在肿瘤患者接受现代抗肿瘤诊疗方案基础上,根据近年不同实体肿瘤治疗领域循证医学证据和指南的更新,结合浙江肿瘤治疗一线中西医结合专家的实际临床经验,充分发挥中医药独特优势,特起草制订本专家共识,提出一系列抗肿瘤全程管理下不同阶段的共识推荐意见,以延长生存为目标,从而加强实体肿瘤的治疗指导和综合干预。With the increasing annual cancer registry data,anti-tumor therapies have evolved from chemotherapy and radiotherapy to the era of targeted and immunotherapy.Multiple factors influence survival benefits under the whole-process layout of anti-tumor manage-ment,including standardized anti-tumor treatment,the completion rate of each line of modern anti-tumor therapy,comorbidities,physical status,the toxicity of modern treatments,intolerable tumor-related symptoms,and socioeconomic factors.Based on the modern anti-tumor diagnostic and therapeutic regimens received by cancer patients,this expert consensus was drafted with the aim of leveraging the unique advantages of traditional Chinese medicine(TCM),based on the latest evidence from evidence-based medicine,updates in treatment guidelines for various solid tumors,and the clinical experience of integrative Chinese and Western medicine experts from Zhejiang.A series of consensus recommendations for different stages of whole-process anti-tumor management are proposed,aiming to prolong survival and enhance the guidance and comprehensive intervention in the treatment of solid tumors.

关 键 词:肿瘤 抗肿瘤治疗 中医药 全程管理 生存获益 

分 类 号:R73[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象